Arcadia Consumer Healthcare Acquires U.S. Rights to Kaopectate from Sanofi

Bansk Group Acquires Arcadia Consumer Healthcare from Avista Capital Partners

September 10, 2021

Consumer Products

Bansk Group, a New York-based private investment firm focused on consumer brands, agreed to acquire Arcadia Consumer Healthcare, a U.S. consumer health platform known for OTC medicines and premium vitamins and supplements, from Avista Capital Partners. The transaction (announced Aug. 9, 2021 and completed Sept. 10, 2021) positions Bansk to expand its consumer health and wellness portfolio and accelerate brand-building and M&A-driven growth.

Arcadia Consumer Healthcare (Bansk Group-backed) Acquires Avrio Health Assets

June 5, 2023

Consumer Products

Arcadia Consumer Healthcare, a Bansk Group-backed consumer healthcare platform, has acquired substantially all of the assets of Avrio Health L.P., adding brands including Betadine, Colace, Senokot and SlowMag to its portfolio. The transaction is intended to expand Arcadia's product offerings and leverage its omni-channel distribution and retail relationships to drive growth.

Cooper Consumer Health Acquires Viatris' Over-the-Counter Business

July 3, 2024

Pharmaceuticals

Cooper Consumer Health has completed the acquisition of the Over-the-Counter (OTC) business of Viatris Inc., following regulatory approvals and worker council consultations. The deal brings more than 200 brands (including Betadine, Saugella, Armolipid and CB12), two manufacturing sites in Mérignac (France) and Confienza (Italy) and an R&D centre in Monza (Italy) into Cooper's platform, doubling Cooper's revenues to approximately €1.2bn.

Avista Capital Partners Acquires WellSpring Consumer Healthcare

August 23, 2022

Consumer Products

Avista Capital Partners completed the acquisition of WellSpring Consumer Healthcare from Audax Private Equity. WellSpring, founded in 1999 and headquartered in Sarasota, Florida, is a developer and marketer of over-the-counter and personal care brands (including Bactine, Bonine, Emetrol and Glaxal Base); Avista plans to support growth through product innovation, distribution expansion and strategic acquisitions.

Kobayashi Pharmaceutical Co., Ltd. Acquires Focus Consumer Healthcare

October 17, 2023

Pharmaceuticals

Kobayashi Pharmaceutical Co., Ltd. (via its subsidiary Kobayashi Healthcare International Inc.) has acquired 100% of Focus Consumer Healthcare, a Chattanooga-based marketer of OTC medicines and dietary supplements. The acquisition gives Kobayashi a foothold in the U.S. supplement market and expands its North American OTC presence by combining Focus's niche brands (GARLIQUE, PAMPRIN, HERPECIN L) with Kobayashi's materials, prescription expertise, and marketing capabilities.

Galecto Inc. Merges with San Diego-based PharmAkea, Inc.

January 9, 2020

Pharmaceuticals

Copenhagen-headquartered Galecto Inc. (a Novo Seeds portfolio company) has merged with San Diego-based PharmAkea, Inc. The combined clinical-stage company will retain the Galecto name, be incorporated in the United States, and combine complementary pipelines in fibrosis and oncology to accelerate development of small-molecule and galectin-targeting therapeutics.